CEP55 Antikörper (AA 151-250)
Kurzübersicht für CEP55 Antikörper (AA 151-250) (ABIN872963)
Target
Alle CEP55 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 151-250
-
Kreuzreaktivität
- Human, Maus
-
Homologie
- Rat,Dog,Sheep,Pig,Horse
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CEP55
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
-
CEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma." in: Oncology letters, Vol. 13, Issue 1, pp. 236-242, (2017) (PubMed).
: "
-
CEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma." in: Oncology letters, Vol. 13, Issue 1, pp. 236-242, (2017) (PubMed).
-
- CEP55 (Centrosomal Protein 55kDa (CEP55))
-
Andere Bezeichnung
- CEP55
-
Hintergrund
-
Synonyms: CT111, URCC6, C10orf3, Centrosomal protein of 55 kDa, Cep55, Up-regulated in colon cancer 6
Background: Plays a role in mitotic exit and cytokinesis. Not required for microtubule nucleation. Recruits PDCD6IP and TSG101 to midbody during cytokinesis.
-
Gen-ID
- 55165
-
UniProt
- Q53EZ4
Target
-